CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell–suppressive function in triple-negative breast cancer and other immunoregulatory settings
The Journal of Immunology · 02.11.2026 · 215 (11)
DOI: 10.1093/jimmun/vkag301 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 13.11.2026. Verfasst von Amirhossein Rahmati und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Foundational Sciences, Mike Petryk School of Dentistry, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Antigens, CD, Erythroid Cells, Apyrase, Triple Negative Breast Neoplasms. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Women and Children's Health Research Institute, Canadian Institutes of Health Research.
Abstract (Originalsprache)
CD71+ erythroid cells (CECs) expand in tumor-bearing hosts and suppress antitumor immunity, but the mechanisms underlying their immunoregulatory activity remain incompletely understood. Here, we identify CD39-mediated purine metabolism as a previously unrecognized suppressive pathway used by CECs. In the 4T1 model of triple-negative breast cancer, CD39 was enriched on CD45+ CECs in the spleen, bone marrow, and tumor microenvironment, whereas CD73 was restricted to a smaller subset. Single-cell RNA sequencing mapped Entpd1 and Nt5e expression across CEC subsets and revealed that CD39+ CECs exhibit a broad immunomodulatory transcriptional program. Functionally, CEC-associated CD39 hydrolyzed extracellular ATP to AMP. CD39+ CECs, but not their CD39− counterparts, suppressed T cell proliferation, and A2A adenosine receptor blockade partially restored these responses. Exogenous AMP also impaired T cell effector function through adenosine receptor signaling, supporting a model in which CEC-derived AMP promotes suppression through trans-cellular adenosine production and potentially direct receptor engagement. TGF-β increased CD39 and CD73 expression on CECs in association with SMAD3 activation, suggesting a potential reinforcing regulatory circuit. CD39+ CECs were also detected during early life, pregnancy, and infections, as well as in human bone marrow, indicating relevance beyond cancer. Collectively, these findings identify the adenosinergic axis as an additional component of the multifactorial suppressive program of CECs and reveal a broader mechanism through which erythroid progenitors regulate immunity across physiological and pathological settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Foundational Sciences, Mike Petryk School of Dentistry, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- Division of Hematology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
- Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada.
- Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, Alberta, Canada.
- Glycomics Institute of Alberta, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Amirhossein Rahmati, Shokrollah Elahi
Förderung
- CIHR
- Women and Children's Health Research Institute
- Canadian Institutes of Health Research
- Women and Children’s Health Research Institute
Zitieren
APA
Rahmati, A., Shahbaz, S., Hnatiuk, M., & Elahi, S. (2026). CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell–suppressive function in triple-negative breast cancer and other immunoregulatory settings. The Journal of Immunology, 215(11). https://doi.org/10.1093/jimmun/vkag301
Vancouver
Rahmati A, Shahbaz S, Hnatiuk M, Elahi S. CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell–suppressive function in triple-negative breast cancer and other immunoregulatory settings. The Journal of Immunology. 2026;215(11). doi:10.1093/jimmun/vkag301
BibTeX
@article{Rahmati2026,
author = {Rahmati, Amirhossein and Shahbaz, Shima and Hnatiuk, Mark and Elahi, Shokrollah},
title = {CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell–suppressive function in triple-negative breast cancer and other immunoregulatory settings},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {11},
doi = {10.1093/jimmun/vkag301}
}
EUVIMED